Advanz Partners With Eisai For Zonisamide

In Europe, The Middle East, Russia And Australia

 
• By Akriti Seth
  
partnership
Advanz pharma and Eisai partner for zonisamide’s European, Middle Eastern, Russian and Australian rights • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business